Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07112339 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes

Name: A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes — clinical trial record (NCT07112339)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 4

SponsorNovo Nordisk A/S

Started2025-08-15

View on ClinicalTrials.gov ↗

This study compares insulin icodec, taken once a week, with other basal insulins, taken once a day, in people with type 2 diabetes.The purpose of this study is to see how well the approved injectable weekly insulin icodec maintains blood sugar levels when compared to approved and available daily injectable basal insulins in people with type 2 diabetes. The participants will either be prescribed weekly insulin icodec or a daily basal insulin (insulin glargine, insulin detemir or insulin degludec) based on current standards for the treatment of type 2 diabetes. The study will last for about 13 months.

Amendment history 2 changes detected by DataLookout

2026-08-12

Primary completion pushed: 2026-08-04 → 2028-03-23

2026-08-12

Completion moved earlier: 2028-08-31 → 2028-03-23

Trial Details

NCT Number	NCT07112339
Lead Sponsor	Novo Nordisk A/S
Conditions	Diabetes Mellitus, Type 2
Enrollment	586 participants
Start Date	2025-08-15
Primary Completion	2028-03-23 (estimated)
Study Completion	2028-03-23 (estimated)
Updated on ClinicalTrials.gov	2026-08-11